Salamol Eco Light breathing from what helps. Salamol eco light breathing, aerosol dosage for inhalation

Instructions for use

Active substances

Form release

Composition

1 Aerosol dose contains: active substance: Salbutamol Sulfate 124 μg, which corresponds to the content of salbutamol 100 μg. Inmogressive substances: hydrofluoronalcan (HFA-134A) - 26.46 mg, ethanol 96% - 3.42 mg.

Pharmacological effect

Broncholitical preparation, selective β2-adrenoreceptor agonist. In therapeutic doses, the drug acts on the β2-adrenoreceptors of the smooth muscles of the bronchi, providing a pronounced bronchhalytic effect, warns and stops bronchospasm, increases the life capacity of the lungs. Prevents the isolation of histamine, a slowly reacting substance from the fat cells and the hemotaxis of neutrophils. Does a slight positive chrono- and inotropic effect on myocardium, expands the coronary artery, almost does not reduce blood pressure. The effect of the drug begins 5 minutes after inhalation administration and continues for 4-6 hours. It has a number of metabolic effects: reduces the content of potassium ions in plasma, affects glycogenolysis and insulin allocation, has hyperglycemic (especially in patients with bronchial asthma) and a lipolytic effect , increases the risk of acidosis.

Pharmacokinetics

Suction, distribution, metabolism of inhalation administration up to 21% of the dose enters the respiratory tract. The rest remains in the device or settles in the rotoglotka and then swallows. The dose that falls into the respiratory tract is absorbed by the tissues of the lungs, without exposing the metabolism in the lungs, and enters the blood flow. If you get into the systemic bloodstream, salbutamol is partially metabolized in the liver and is removed mainly by the kidneys unchanged or in the form of phenolic sulfate. The dose received in the gastrointestinal tract is absorbed and exposed to intensive metabolism at the first passage through the liver, turning into phenolic sulfate. Salbutamola Plasma is 10%. Cmax Blood Plasma - 30 ng / ml.t1 / 2-37-5 h. Vysladeniyeviews mainly by the kidneys unchanged and in the form of a conjugate. Most of the dose of salbutamola entered in / in, inside or inhaled, is excreted within 72 hours.

Indications

Prevention and relief of bronchospasm with bronchial asthma, chronic obstructive diseases of the lungs (COPD), chronic bronchitis, lung emphysema.

Contraindications

Increased sensitivity to any component of the drug, heart rate disorders (paroxysmal tachycardia, political ventricular extrasystolia), myocarditis, heart patterns, aortic stenosis, coronary heart disease, tachyritium, thyrotoxicosis, decompensated diabetes, glaucoma, epilepsy, pyloroduodenal narrowing, renal or liver failure , pregnancy, simultaneous reception not selective beta-adrenoblastors, children's age up to 2 years.

Precautions

The drug should be stored in an inaccessible for children protected from direct sunlight location, at a temperature not higher than 25 ° C; Do not freeze.

Application in pregnancy and breastfeeding

The drug is contraindicated to use during pregnancy. During lactation (breastfeeding), only in cases where the expected benefit for the mother exceeds any potential risk to the child.

Method of application and dose

Adults and children over 12 years old: 100-200 μg Salamol eco light breathing (1-2 inhalation doses) to relocate seizures. To control the strength of an easy severity - 1-2 doses 1 -4 times a day and the average severity of the disease - in the same dosage in combination with other anti-asthma drugs. For the prevention of the asthma of physical effort - 20-30 minutes before the load of 1-2 doses on the reception. Choose from 2 to 12 years: when the attack of bronchial asthma is developed, as well as to prevent the bronchial asthma attacks associated with the effects of allergen or caused by exercise, The recommended dose is 100-200 μg (1 or 2 inhalation). The dry dose of Salamola Eco light breathing should not exceed 800 μg (8 inhalation).

Side effects

Salamol Eco Light breathing can cause tremors to fingers, which is a typical side effect for all B-2-adrenoreceptor agonists. Headache, dizziness, increased excitability, anxiety, sleep disorder, insomnia, expansion of peripheral vessels (hyperemia of the skin of the face), a slight compensatory increase in heart rate, increase blood pressure. Hypersensitivity reactions may develop (including angioedema edema, urticule, erythema, nasal congestion, bronchospasm, arterial hypotension and collapse); Muscular cramps, nausea, vomiting, dyspepsia. Ingulation drugs can cause paradoxical bronchospasm. Inhalation drugs can cause irritation of the oral mucosa and pharynx sheath (pharyngitis), cough. Salbutamol can cause hypocalemia, which can represent a serious danger to the patient, as well as reversible metabolic disorders, for example, an increase in blood glucose concentration. The drug may cause excitement and increase in motor activity in children. It is possible to appear arrhythmias (including atrial fibrillation, superstricular tachycardia and extrasystolism).

Overdose

Symptoms: nausea, vomiting, increased excitability, hallucinations, tachycardia, ventricular flutter, expansion of peripheral vessels, decreased blood pressure, hypoxemia, acidosis, hypokalemia, hyperglycemia, muscle tremor, headache: Cancellation of the drug, reception of cardio selective beta adrenoblockers; If necessary, spend symptomatic therapy. In suspected an overdose, the level of potassium in serum should be monitored.

Interaction with other drugs

Theophylline and other xanthines with simultaneous use with salbutomol increase the likelihood of tachyarithmiums; And means for inhalation anesthesia, levodopa - heavy ventricular arrhythmias. It is recommended to simultaneously apply the preparation of Salamol Eco light breathing and non-selective beta-adrenerblockers (such as propranolol). Mao and tricyclic antidepressants enhance the action of salbutamola and can lead to a sharp decrease in blood pressure simultaneously The use of salbutamol enhances the effect of drugs with a stimulating effect on the central nervous system, the side effect of the thyroid hormones, cardiac glycosides. When simultaneous use, salbutamol reduces the effectiveness of antihypertensive drugs, nitrates. When simultaneous use with Ksanthina derivatives, GKS, diuretics are hypocalemia. means (including inhalation) can contribute to an increase in intraocular pressure.

special instructions

In patients with severe form or with an unstable stream of bronchial asthma, the use of bronchodulators should not be the main or only method of therapy. Patient needs to be prevented about the need to consult a doctor if the use of the drug Salamol Eco light breathing in a standard dose becomes less efficient or less long (the effect of the drug should be maintained at least 3 hours). The use of salbutamola can lead to bronchospasm and various complications (up to A sudden fatal outcome), in connection with the next inhalations, it is necessary to take breaks in a few hours. The need for the need for the use of inhalation beta2-adrenomimetics with a short duration of action to control the symptoms of bronchial asthma indicates the exacerbation of the disease. In such cases, the patient's treatment plan should be revised and resolve the issue of appointing or increasing the dose of inhalation or systemic GKS. Beta2-adrenomimetics can lead to hypokalemia. It is recommended that it is recommended for particular caution in the treatment of severe bouts of bronchial asthma, since in these cases hypocalemia may increase as a result of the simultaneous use of xanthine derivatives, GKS, diuretics, as well as due to hypoxia. In such situations, it is necessary to control the level of potassium in the blood. less efficient at low temperatures. When cooling the canopy, it is recommended to get it from a plastic case and warm your hands for a few minutes.

Dosage form

The inhalation aerosol dosed, activated by inhale, in the form of a white suspension, which, when spraying on the glass, forms a spat of white.

Composition

salbutamol sulfate124 μg,

What corresponds to the content of Salbutamola100 μg

Auxiliary substances: ethanol, hydrophorelkan (HFA-134A).

Pharmacodynamics

Bronching agent. Beta adrenomimetics with predominantly influence on beta2-adrenoreceptors. In therapeutic doses, the drug acts on the beta2-adrenoreceptors of the smooth muscles of bronchi, providing a pronounced bronchhalytic effect, warns and stops bronchospasm, increases the life capacity of the lungs. Prevents the isolation of histamine, a slowly reacting substance from the fat cells and the factors of chemotaxis neutrophils. It has a minor positive chrono and inotropic effect on myocardium, expanding coronary artery, practically does not reduce blood pressure.

It has a tocolic effect: reduces the tone and the contractile activity of myometrium. The effect of the drug begins 5 minutes after inhalation administration and continues for 4-6 hours. It has a number of metabolic effects: reduces the content of potassium ions in plasma, affects glycogenolysis and insulin allocation, has hyperglycemic (especially in patients with bronchial asthma) and a lipolytic effect , increases the risk of acidosis

Pharmacokinetics

After inhalation administration, up to 21%, the dose enters the respiratory tract. The rest remains in the instrument or settles in the rotoglotka and then swallows.

A part of the dose that falls into the respiratory tract is absorbed by the tissues of the lungs, does not expose biotransformation and enters the bloodstream. If you get into the systemic blood flow, salbutamol is partially metabolized in the liver and is removed mainly by the kidneys unchanged or in the form of phenolic sulfate.

A dose part that falls into the gastrointestinal tract is absorbed and exposed to the effect of the "first passage" through the liver, turning into phenolic sulfate.

Salbutamola binding with plasma proteins is 10%. Cmax in blood plasma - 30 ng / ml.t1 / 2-37-5 h.

It is removed mainly by the kidneys unchanged and in the form of a conjugate. Most of the dose of salbutamola entered inhalation is excreted within 72 hours.

Side effects

From the CNS side: tremor of hands (typical side effect for all beta2-adreminimetics), headache, dizziness, increased excitability, anxiety, sleep disorder, insomnia. The drug may cause excitation and increase in motor activity in children.

From the side of the cardiovascular system: expansion of peripheral vessels (hyperemia of the skin of the face), a slight compensatory increase in heart rate, increased blood pressure. The appearance of arrhythmias (including atrial fibrillation, superstricular tachycardia and extrasystole) is possible.

Allergic reactions: in isolated cases - angioedema edema, urticaria, erythema, nasal congestion, bronchospasm, arterial hypotension, collapse.

From the digestive system: nausea, vomiting, dyspepsia.

From the respiratory system: paradoxical bronchospasm, irritation of the mucous membrane of the oral sheath and pharynx (pharyngitis), cough.

From the metabolism side: hypokalemia (may be a serious danger to the patient), reversible hyperglycemia.

Others: muscle cramps

Features of sale

prescription

Special conditions

In patients with severe form or with an unstable stream of bronchial asthma, the use of bronchodulators should not be the main or only method of therapy. The patient must be prevented about the need to consult a doctor if the use of the drug Salamol Eco light breathing in a standard dose becomes less efficient or less long (the effect of the drug should be maintained at least 3 hours).

Frequent use of salbutamola can lead to a strengthening of bronchospasm and various complications (up to a sudden fatal outcome), in connection with which interruptions should be taken between the next inhalations.

Improving the need for the use of inhalation beta2-adrenomimetics with a short duration of action to control the symptoms of bronchial asthma indicates the exacerbation of the disease. In such cases, the patient's treatment plan should be revised and to resolve the issue of appointing or increasing the dose of inhalation or systemic GKS.

Therapy of beta2-adrenomimetics can lead to hypokalemia. It is recommended that it is recommended for particular caution in the treatment of severe bouts of bronchial asthma, since in these cases hypocalemia may increase as a result of the simultaneous use of xanthine derivatives, GKS, diuretics, as well as due to hypoxia. In such situations it is necessary to control the level of potassium in serum.

Caller with the preparation of Salamol Eco Light breathing can not be pumped, disassembled or throwing into the fire, even if it is empty.

Like most other means for inhalations in aerosol packages, the drug Salamol Eco Light breathing may be less effective at low temperatures. When cooling the can, it is recommended to get it from a plastic case and warm your hands for a few minutes.

Indications

Prevention and relief of bronchospasm:

With bronchial asthma;

With chronic obstructive pulmonary disease (COPD);

In chronic bronchitis;

With lung emphysema

Contraindications

Heart rate disorders (paroxysmal tachycardia, political ventricular extrasystole), tachyarhythmias;

Myocarditis;

Heart defects, aortic stenosis;

IBS, Tahiaritmia;

Thyrotoxicosis;

Decompensated diabetes;

Glaucoma;

Epilepsy;

Pyloroduodenal narrowing;

Liver failure;

Renal failure;

Pregnancy;

Simultaneous reception of non-selective beta-adrenoblasts;

Children's age up to 2 years;

Increased sensitivity to any component of the drug.

With caution, the drug is prescribed with chronic heart failure, hyperthyroidism, arterial hypertension, feochromocytoma.

Medicinal interaction

Theophylline and other xanthines with simultaneous use with salbutomol increase the likelihood of tachyarithmiums; And means for inhalation anesthesia, levodopa - heavy ventricular arrhythmias.

Mao inhibitors and tricyclic antidepressants enhance the action of salbutamola and can lead to a sharp decrease in blood pressure.

With the simultaneous use of salbutamol enhances the effect of drugs with a stimulating effect on the CNS, the side effect of the thyroid hormones, heart glycosides.

With the simultaneous use of salbutamol reduces the effectiveness of antihypertensive drugs, nitrates.

With simultaneous use with xanthine derivatives, GKS, diuretics can enhance hypokalemia.

Prices for Salamol Eco Light Breath in other cities

Salamol Eco Easi Breathe

Registration number:

P N014097 / 01-170407

Trade name of the drug: Salamol eco light breathing.

International UnPatented Name:

Salbutamol.

Dosage form:

Inhalation aerosol dosed activated inhale.

Composition:

Each inhaler contains 200 doses of the drug.
Active substance
One inhalation dose contains salbutamol sulfate - 124 μg is equivalent to salbutamol - 100 μg
Excipients: Ethanol, hydrofluoronalcan (HFA-134A).

Description:
Aerosol for inhalations in an aluminum pressure can with an exhaust valve and a package. There must be no external damage, corrosion or leaks. The contents of the canister is a suspension, which, when spraying on the glass, sells white spot. The cartridge is placed in a inhaler consisting of two parts and a safety cover.

Pharmacotherapeutic Group: Bronching agent - B-2-adrenomimetics selective. ATX code: R03AC02.

Pharmacological properties

Pharmacodynamics
Salbutamol is a selective antagonist of B-2-adrenoreceptors. In the therapeutic doses, it acts on the B-2-adrenoreceptors of the smooth muscles of the bronchi, providing a pronounced bronchhalytic effect, warns and stops bronchospasm, increases the life capacity of the lungs. Prevents the isolation of histamine, a slowly reacting substance from the fat cells and the factors of chemotaxis neutrophils. It causes a minor positive chrono and inotropic effect on myocardium, expanding coronary arteries, practically does not reduce blood pressure. It has a tocolic action: lowers the tone and the contractile activity of myometrium. The effect of the drug begins 5 minutes after inhalation administration and continues for 4-6 hours. It has a narrow M Gabolic effects: Reduces the content of K + in plasma, affects the glycogenolysis and insulin allocation, it has hyperglycemic (especially in patients with bronchial asthma) and a lipolytic effect, increases the risk of acidosis.

Pharmacokinetics
After inhalation administration, up to 21%, the dose enters the respiratory tract. The rest of the part is delayed in the instrument or settles in the rotoglotka and then swallows. Part of the dose that remains in the respiratory tract is absorbed by the tissues of the lungs, without exposing the metabolism in the lungs, and enters the bloodstream. When entering the systemic blood flow, it can be metabolized in the liver and is removed mainly by the kidneys unchanged or in the form of phenolic sulfate.

Part of the dose entered the gastrointestinal tract is absorbed and exposed to intense metabolism during the first passage through the liver, turning into phenolic sulfate. The unchanged preparation and conjugate are predominantly by the kidneys. Most of the dose of salbutamola administered intravenously, inside or inhaled, is output within 72 hours. The degree of binding of salbutamola with plasma proteins is 10%. The maximum concentration in the blood plasma is 30 ng / ml. Half-life - 3.7-5 h.

Indications for use
Prevention and relief of bronchospasm with bronchial asthma, chronic obstructive diseases of the lungs (COPD), chronic bronchitis, lung emphysema.

Contraindications
Increased sensitivity to any component of the drug, heart rate disorders (paroxysmal tachycardia, political ventricular extrasystolia), myocarditis, heart patterns, aortic stenosis, coronary heart disease, tachyritium, thyrotoxicosis, decompensated diabetes, glaucoma, epilepsy, pyloroduodenal narrowing, renal or liver failure , pregnancy, simultaneous reception not selective beta-adrenoblastors, children's age up to 2 years.

With caution - chronic heart failure, hyperthyroidism, arterial hypertension, pheochromocytoma.

Application during pregnancy and lactation
Contraindicated during pregnancy. During the lactation period, it is assigned only in cases where the expected benefit for the mother exceeds any possible risk for the child.

Method of application and dose
Adults and children over 12 years old: 100-200 μg Salamol eco light breathing (1-2 inhalation doses) to relocate attacks choking. To control the strength of an easy severity - 1-2 doses 1 -4 times a day and the average severity of the disease - in the same dosage in combination with other anti-asthma drugs. For the prevention of asthma of physical effort - 20-30 minutes before the load of 1-2 doses on reception.

Children from 2 to 12 years old: With the development of the attack of bronchial asthma, as well as to prevent the attacks of bronchial asthma associated with the effects of allergen or caused by exercise, the recommended dose is 100-200 μg (1 or 2 inhalation).

Daily dose of Salamola Eco Light breathing should not exceed 800 μg (8 inhalations).

SIDE EFFECT
Salamol Eco Light breathing can cause tremors to fingers, which is a typical side effect for all B-2-adrenoreceptor agonists. Headache, dizziness, increased excitability, anxiety, sleep disorder, insomnia, expansion of peripheral vessels (hyperemia of the skin of the face), a slight compensatory increase in heart rate, increase blood pressure. Hypersensitivity reactions may develop (including angioedema edema, urticule, erythema, nasal congestion, bronchospasm, arterial hypotension and collapse); Muscular cramps, nausea, vomiting, dyspepsia.

Inhalation drugs can cause paradoxical bronchospasm. Inhalation drugs may cause irritation of the mucous membrane of the oral cavity and pharynx (pharyngitis), cough.

Therapy salbutomol can cause hypokalemia, which can represent a serious danger to the patient, as well as reversible metabolic disorders, for example, an increase in blood glucose concentration. The drug may cause excitation and increase in motor activity in children.

The appearance of arrhythmias (including atrial fibrillation, superstricular tachycardia and extrasystole) is possible.

OVERDOSE
Symptoms: nausea, vomiting, increased excitability, hallucinations, tachycardia, ventricular flutter, expansion of peripheral vessels, decrease in blood pressure, hypoxemia, acidosis, hypokalemia, hyperglycemia, muscle tremor, headache.

Treatment: Cancellation of the drug, cardiolective beta adrenoblays; Symptomatic therapy. In suspected an overdose, the level of potassium in serum should be monitored.

Interaction with other drugs
Theophylline and other xanthines with simultaneous use with salbutomol increase the likelihood of tachyarithmiums; Means for inhalation anesthesia, levodopa - heavy ventricular arrhythmias.

Monoaminoxidase inhibitors and tricyclic antidepressants enhance the action of salbutamola and can lead to a sharp pressure decrease.

Salbutamol enhances the action of stimulants of the central nervous system, the side effect of the hormones of the thyroid gland, heart glycosides. Reduces the effectiveness of hypotensive drugs, nitrates.

Hypokalemia may be intensified as a result of the simultaneous use of xanthine derivatives, glucocorticosteroids (GKS), diuretics.

Simultaneous purpose with anticholinergic agents (including inhalation) can contribute to an increase in intraocular pressure.

SPECIAL INSTRUCTIONS
In patients with severe or unstable bronchial asthma, the use of bronchodulators should not be the main or only method of therapy. If the action of a conventional dose Salamol Eco light breathing becomes less efficient or less long (the effect of the drug should be maintained at least 3 hours), the patient should consult a doctor.

Part of the use of salbutamola can lead to an increase in bronchospasm, sudden death, and therefore between the receptions of the next doses of the drug, it is necessary to take breaks in several hours.

Improving the need for the use of inhalation agonists of B-2-adrenoreceptors with a short duration of action to control the symptoms of bronchial asthma indicates the exacerbation of the disease. In such cases, the patient's treatment plan should be revised and to resolve the issue of appointing or increasing the dose of inhalation or systemic GKS.

Therapy of B-2-adrenoreceptor agonists can lead to hypokalemia. It is recommended that it is recommended for particular caution in the treatment of severe bouts of bronchial asthma, since in these cases hypocalemia may increase as a result of the simultaneous use of xanthine derivatives, GKS, diuretics, as well as due to hypoxia. In such situations it is necessary to control the level of potassium in serum. Callery with Salamol Eco Light breathing can not be poured, disassembled or throwing into the fire, even if it is empty. Like most other means for inhalations in aerosol packages, Salamol Eco Light breathing may be less effective at low temperatures. When cooling the canopy, it is recommended to get it from a plastic case and warm your hands for a few minutes.

Instructions for the patient inhaler

Instructions for using inhaler
Shake the inhaler several times. Then, holding a inhaler in a vertical position, open the cover. Make a deep breath. Tightly embrace mouthpiece lips. Make sure your hand does not light up the ventilation holes on the top of the inhaler and that you hold the inhaler in a vertical position. Make a slow maximum breath through the mouthpiece. Hold your breath for 10 seconds or so much as convenient for you. Then remove the inhaler from the mouth and slowly exhale. After use, continue to keep the inhaler in a vertical position. Close the lid. If you need to make less than one inhalation, close the lid, wait at least one minute, and then repeat the inhalation process.

Inhaler cleaning
Unscrew the top of the inhaler. Pull out a metal spray. Rinse the lower part of the inhaler in warm water and dry. Insert the balloon in place. Close the lid and screw the upper part of the inhaler to its housing. Do not wash the upper part of the inhaler. If the inhaler works incorrectly, unscrew the upper part of it and manually press the canister.

Form release
Inhalation aerosol Dosage activated by inhale 100 μg / dose. 200 doses of active substance in an aluminum canopy filled under pressure aerosol. The aluminum canopy is located in an aerosol inhaler activated by inhale (light breathing). The aerosol inhaler with the canopy is placed in a cardboard pack together with instructions for use.

SHELF LIFE
3 years.
Do not use after the expiration date.

STORAGE CONDITIONS
At a temperature not higher than 30 ° C, protecting against direct sunlight. Do not freeze. Keep out of the reach of children.

Conditions of vacation from pharmacies
On prescription.

MANUFACTURER
Norton Vierford, Ireland Iidia Industrial Park, Cork Road, Vyterford, Ireland
Moscow office: 107031, Moscow, Dmitrovsky Per., House 9,

Latin name

Salamol Eco Easi Breathe

Active substance

Form release

inhalation aerosol activated by inhalation (light breathing)

Owner / registrar

Norton Waterford.

International Classification of Diseases (ICD-10)

J43 Emphysema J44 Other Chronic Obstructive Pulmonary Disease J45 Asthma

Pharmacological group

Broncholic drug - beta2 adrenomimetics

pharmachologic effect

Broncholic preparation, selective β 2 -adrenoreceptor agonist. In the therapeutic doses, the drug acts on β 2 -adrenoreceptors of a smooth muscle of bronchi, providing a pronounced bronchhalytic effect, warns and stops bronchospasm, increases the life capacity of the lungs. Prevents the isolation of histamine, a slowly reacting substance from the fat cells and the factors of chemotaxis neutrophils.

Causes a minor positive chrono and inotropic effect on myocardium, expands coronary artery, practically does not reduce blood pressure.

It has a tocolic effect: reduces the tone and the contractile activity of myometrium. The effect of the drug begins 5 minutes after inhalation administration and continues for 4-6 hours. It has a number of metabolic effects: reduces the content of potassium ions in plasma, affects glycogenolysis and insulin allocation, has hyperglycemic (especially in patients with bronchial asthma) and a lipolytic effect , increases the risk of acidosis.

Pharmacokinetics

Suction, distribution, metabolism

After inhalation administration, up to 21%, the dose enters the respiratory tract. The rest remains in the instrument or settles in the rotoglotka and then swallows.

A part of the dose that falls into the respiratory tract is absorbed by the tissues of the lungs, without being subjected to metabolism in the lungs, and falls into the bloodstream. If you get into the systemic blood flow, salbutamol is partially metabolized in the liver and is removed mainly by the kidneys unchanged or in the form of phenolic sulfate.

A part of the dose entered into the gastrointestinal tract is absorbed and subjected to intense metabolism at the "first passage" through the liver, turning into phenolic sulfate.

Salbutamola binding with plasma proteins is 10 %. C MAX in blood plasma - 30 ng / ml.t 1/2 - 3.7-5 h.

Election

It is removed mainly by the kidneys unchanged and in the form of a conjugate. Most of the dose of salbutamola entered in / in, inside or inhaled, is excreted within 72 hours.

Prevention and relief of bronchospasm:

With bronchial asthma;

With chronic obstructive pulmonary disease;

In chronic bronchitis;

With lung emphysema.

Heart rate disorders (paroxysmal tachycardia, political ventricular extrasystole, tachyarhythmia);

Myocarditis;

Heart defects, aortic stenosis;

Thyrotoxicosis;

Decompensated diabetes;

Glaucoma;

Epilepsy;

Pyloroduodenal narrowing;

Liver failure;

Renal failure;

Pregnancy;

Simultaneous reception of non-selective beta-adrenoblasts;

Children's age up to 2 years;

Increased sensitivity to the components of the drug.

FROM caution Prescribed the drug in chronic heart failure, hyperthyroidism, arterial hypertension, pheochromocytoma.

From the nervous system: Tremor hands (typical side effect for all beta 2 -adrenomimetics), headache, dizziness, increased excitability, anxiety, sleep disorder, insomnia. The drug may cause excitation and increase in motor activity in children.

From the side of the cardiovascular system: Expansion of peripheral vessels (hyperemia of the skin of the face), a slight compensatory increase in heart rate, increased blood pressure. The appearance of arrhythmias (including atrial fibrillation, superstricular tachycardia and extrasystole) is possible.

Allergic reactions: angioedema edema, urticaria, erythema, nasal congestion, bronchospasm, arterial hypotension, collapse.

From the digestive system: Nausea, vomiting, dyspepsia.

Local reactions: irritation of the mucous membrane of the oral cavity and pharynx (pharyngitis), cough.

From the respiratory system: Paradoxical bronchospasm.

From the metabolism: Hypologiamia is possible (may be a serious danger to the patient), reversible hyperglycemia.

Others: Muscular cramps.

Overdose

Symptoms: Nausea, vomiting, increased excitability, hallucinations, tachycardia, ventricular fluttering, expansion of peripheral vessels, decreased blood pressure, hypoxemia, acidosis, hypokalemia, hyperglycemia, muscle tremor, headache.

Treatment: Cancellation of the drug, reception of cardiolective beta-adrenoblockers; If necessary, spend symptomatic therapy. In suspected an overdose, the level of potassium in serum should be monitored.

special instructions

In patients with severe form or with an unstable stream of bronchial asthma, the use of bronchodulators should not be the main or only method of therapy. The patient must be prevented about the need to consult a doctor if the use of the drug Salamol Eco light breathing in a standard dose becomes less efficient or less long (the effect of the drug should be maintained at least 3 hours).

Frequent use of salbutamola can lead to a strengthening of bronchospasm and various complications (up to a sudden fatal outcome), in connection with which interruptions should be taken between the next inhalations.

Increasing the need for the use of inhalation beta 2 -adrenomimetics with a short response to the control of symptoms of bronchial asthma indicates the exacerbation of the disease. In such cases, the patient's treatment plan should be revised and to resolve the issue of appointing or increasing the dose of inhalation or systemic GKS.

Beet's therapy 2 -adrenomimetics can lead to hypokalemia . It is recommended that it is recommended for particular caution in the treatment of severe bouts of bronchial asthma, since in these cases hypocalemia may increase as a result of the simultaneous use of xanthine derivatives, GKS, diuretics, as well as due to hypoxia. In such situations it is necessary to control the level of potassium in serum.

Caller with the preparation of Salamol Eco Light breathing can not be pumped, disassembled or throwing into the fire, even if it is empty.

Like most other means for inhalations in aerosol packages, the drug Salamol Eco Light breathing may be less effective at low temperatures. When cooling the canopy, it is recommended to get it from a plastic case and warm your hands for a few minutes.

With renal failure

The drug is contraindicated in renal failure.

In case of violation of the functions of the liver

The drug is contraindicated in hepatic insufficiency.

Application in pregnancy and breastfeeding

The drug is contraindicated to use during pregnancy. During lactation (breastfeeding), only in cases where the expected benefit for the mother exceeds any potential risk to the child.

Medicinal interaction

Theophylline and other xanthines with simultaneous use with salbutomol increase the likelihood of tachyarithmiums; And means for inhalation anesthesia, levodopa - heavy ventricular arrhythmias.

Mao inhibitors and tricyclic antidepressants enhance the action of salbutamola and can lead to a sharp decrease in blood pressure.

With the simultaneous use of salbutamol enhances the effect of drugs with a stimulating effect on the CNS, the side effect of the thyroid hormones, heart glycosides.

With the simultaneous use of salbutamol reduces the effectiveness of antihypertensive drugs, nitrates.

With simultaneous use with xanthine derivatives, GKS, diuretics can enhance hypokalemia.

Simultaneous purpose with anticholinergic agents (including inhalation) can contribute to an increase in intraocular pressure.

Adults and children over 12 years old for putting bouts of bronchospasmSalamol Eco Light breathing is prescribed 100-200 μg (1-2 inhalation doses). For control over the stream of easy severity - 1-2 doses of 1-4 times / day; for middle severity of the disease - In the same dose in combination with other anti-asthma drugs. For asthma Prevention of Physical Efforts The drug is used for 20-30 minutes before the load of 100-200 μg (1-2 inhalation doses) to receive.

Children aged 2 to 12 yearsunder development attack of bronchial asthmaas well as for prevention attacks of bronchial asthma associated with the effects of allergen or physical activity caused byThe recommended dose is 100-200 μg (1 or 2 inhalation).

Daily dose of the drug Salamol Eco Light breathing should not exceed 800 μg (8 inhalation).

Instructions for using inhaler

Before use, you should shake the inhaler several times. Then, holding a inhaler in a vertical position, open the lid. Make a deep exhale. Tightly embrace mouthpiece lips. It is necessary to make sure that the hand does not light up the ventilation holes on the top of the inhaler, and that the inhaler is in a vertical position. Make a slow maximum breath through the mouthpiece, delay breathing for 10 seconds or as well as it is convenient. Then you need to remove the inhaler from the oral cavity and slowly exhale. After use, continuing to keep the inhaler in the vertical position, close the lid. If you need to do more than one inhalation, the cover is closed and, waiting, at least one minute, repeat the inhalation process.

Inhaler cleaning

The top of the inhaler must be unscrewed and pull out the metal spray. Then rinse the lower part of the inhaler in warm water and dry. Then the can insert the balloon. Close the lid and fasten the top of the inhaler to its housing. The upper part of the inhaler is not washed. If the inhaler works incorrectly, unscrew its upper part and manually press the spray.

Storage conditions and shelf life

The drug should be stored in an inaccessible for children protected from direct sunlight location, at a temperature not higher than 25 ° C; Do not freeze. Shelf life - 3 years.

Vacation from pharmacies

The drug is released by the prescription.

Salamol Eco Light Breath: Brief Instructions for Application

• The aerosol is prescribed to relieve spasm and expanding lumen in bronchi with respiratory diseases.
• The course of treatment and the dosage of the drug is appointed by a doctor individually.
• The effect of using an aerosol comes in a few minutes and lasts up to six hours.
• Admission is allowed from a biennium in children.
• Not used for the treatment of women during pregnancy.
• Do not allow medicine to enter the mucous eye.
• Keep an aerosol in an inaccessible place for children's hands.

Side effects of the drug Salamola Eco Light Breathing

• Excitation and increase in activity in childhood
• Sensation of heartbeat
• Enhance arterial pressure
• Inpropant muscle hands cuts
• Anxiety, excitement
• Violation of sleep duration
• Circling of the head
• Disruption of digestion function
• Vomit urge, nausea
• Dryness mucosa of rotoglotka
• Harfish, redness, itching
• Reducing potassium content in the body
• Individual intolerance to the drug

You can purchase Salamol Eco Light Breath in the Internet Pharmacy Website

Large selection of medicines at affordable prices.

Necessary questions on the drug (testimony, composition, instruction, how to accept, side effects, overdose) can be on the telephone online pharmacy.

Prevention and relief of bronchospasm with:

• Bronchial asthma.
• Chronic obstructive pulmonary disease (COPD).
• Chronic bronchitis.
• Emphysema of the lungs.

Contraindications for use Salamole Eco Light Breath

• Cardiac disorders (paroxysmal tachycardia, political ventricular extrasystole), tachyarhythmia.
• Myocarditis.
• Diggle hearts, aortic stenosis.
• Coronary heart disease.
• Thyrotoxicosis.
• Decompensated diabetes mellitus.
• Glaucoma.
• Epilepsy.
• Pyloroduodenal narrowing.
• Liver failure.
• Renal failure.
• Pregnancy.
• Simultaneous reception of non-selective beta adrenoblockers.
• Children's age up to 2 years.
• Increased sensitivity to any component of the drug.

Carefully Prescribed the drug in the following cases:

• Chronic heart failure.
• Hyperthyroidism.
• Arterial hypertension.
• Feochromocytoma.

Adults and children over 12 years old - 100-200 μg Salamol Eco (1 -2 inhalation doses) to relocate seizures of suffocation.
To control the strength of asthma, a mild severity - 1-2 doses 1 - 4 times a day and a moderate severity of the disease - in the same dosage in combination with other anti-asthma drugs.
For the prevention of asthma of physical effort - 20-30 minutes before the load of 1-2 doses on reception.
Children from 2 to 12 years old when developing an attack of bronchial asthma, as well as to prevent the attacks of bronchial asthma associated with the effects of allergen or by physical activity, the recommended dose is 100-200 μg (1 or 2 inhalation).
The daily dose of salbutamola should not exceed 800 μg (8 inhalation).

Application Salamol Eco Light Breathing during pregnancy and breastfeeding

The drug is contraindicated to use during pregnancy. During lactation (breastfeeding), only in cases where the expected benefit for the mother exceeds any potential risk to the child.

pharmachologic effect

Salbutamol is a selective antagonist? -2-adrenoreceptors. In therapeutic doses, it acts on? -2-adrenoreceptors smooth musculature of bronchi, providing a pronounced bronchodist effect, warns and stops bronchospasm, increases the life capacity of the lungs. Prevents the isolation of histamine, a slowly reacting substance from the fat cells and the factors of chemotaxis neutrophils. It causes a minor positive chrono and inotropic effect on myocardium, expanding coronary arteries, practically does not reduce blood pressure. Tocolytic action has: lowers the tone and the contractile activity of the myometrium. The effect of the drug begins 5 minutes after inhalation administration and continues for 4-6 hours. It has a number of metabolic effects: reduces the content of K + in plasma, affects glycogenolysis and insulin allocation, has hyperglycemic (especially in patients with bronchial asthma) and a lipolytic effect, increases the risk of acidosis.

Side effects Salamol Eco Light Breath

From the CNS: Tremor of hands (typical side effect for all beta2-adreminimetics), headache, dizziness, increased excitability, anxiety, sleep disorder, insomnia. The drug may cause excitation and increase in motor activity in children.

From the side of the cardiovascular system: Expansion of peripheral vessels (hyperemia of the skin of the face), a slight compensatory increase in heart rate, increased blood pressure. The appearance of arrhythmias (including atrial fibrillation, superstricular tachycardia and extrasystole) is possible.

Allergic reactions: In isolated cases - angioedema edema, urticaria, erythema, nasal congestion, bronchospasm, arterial hypotension, collapse.

From the digestive system: Nausea, vomiting, dyspepsia.

From the respiratory system: Paradoxical bronchospasm, irritation of the mucous membrane of the oral cavity and pharynx (pharyngitis), cough.

From the metabolism: Hypologiamia is possible (may be a serious danger to the patient), reversible hyperglycemia.

Others: Muscular cramps.

special instructions

In patients with severe or unstable bronchial asthma, the use of bronchodulators should not be the main or only method of therapy. If the action of the usual dose of Salamol Eco becomes less efficient or less long (the effect of the drug should be maintained at least 3 hours), the patient should consult a doctor. Frequent use of salbutamola can lead to an increase in bronchospasm, sudden death, and therefore between the receptions of the next doses of the drug, it is necessary to take breaks in several hours. Improving the need to apply inhalation agonists? -2-adrenoreceptors with a short duration of action to control the symptoms of bronchial asthma indicates the exacerbation of the disease. In such cases, the patient's treatment plan should be revised and to resolve the issue of appointing or increasing the dose of inhalation or systemic glucocorticosteroids (GKS). Therapy with agonists? -2-adrenoreceptors can lead to hypokalemia. It is recommended that it is recommended for particular caution in the treatment of severe bouts of bronchial asthma, since in these cases hypocalemia may increase as a result of the simultaneous use of xanthine derivatives, GKS, diuretics, as well as due to hypoxia. In such situations it is necessary to control the level of potassium in serum. Callery with Salamol Eco can not pour, disassemble or throw into the fire, even if it is empty. Like most other means for inhalations in aerosol packages, Salamol Eco may be less effective at low temperatures. When cooling the canopy, it is recommended to get it from a plastic case and warm your hands for a few minutes.

Overdose

Symptoms: Nausea, vomiting, increased excitability, hallucinations, tachycardia, ventricular fluttering, expansion of peripheral vessels, decrease in blood pressure, hypoxemia, acidosis, hypokalemia, hyperglycemia, muscle tremor, headache.

Treatment:cancellation of the drug, cardiolective beta-adrenoblays; Symptomatic therapy. In suspected an overdose, the level of potassium in serum should be monitored.

Medicinal interaction

Theophylline and other xanthines with simultaneous use with salbutomol increase the likelihood of tachyarithmiums; Means for inhalation anesthesia, levodopa - heavy ventricular arrhythmias. It is not recommended to simultaneously apply Salamole Eco and non-selective Beta-adrenoreceptor blockers, such as propranolol. Monoaminoxidase inhibitors and tricyclic antidepressants reinforce the action of salbutamola and can lead to a sharp pressure reduction. Salbutamol enhances the action of stimulants of the central nervous system, the side effect of the hormones of the thyroid gland, heart glycosides. Reduces the effectiveness of hypotensive drugs, nitrates. Hypokalemia can be intensified as a result of the simultaneous use of xanthine derivatives, glucocorticosteroids, diuretics. Simultaneous purpose with anticholinergic agents (including inhalation) can contribute to an increase in intraocular pressure.

Storage conditions

Store at a temperature not higher than 30 ° C, protecting against direct sunlight.